Glenmark's Zita portfolio of medicines have been benefiting around 1.75 million Type 2 diabetic patients annually
This FDC has been launched under the brand name Zita-PioMet, and contains Teneligliptin (20 mg) + Pioglitazone (15 mg) + Metformin (500mg/1000mg) in a sustained release (SR) formulation
The domestic business has registered a single-digit growth on the huge base of last year and this was driven by robust demand across established therapies and brands
These medicines have low risk of hypoglycemia, provide beta cell protection, offer cardio-renal benefits and are safe for patients with kidney or liver conditions and senior citizens
Glenmark is the first company in India to market the innovative FDC of Indacaterol
The six-layer packaging ensures that external media such as bacteria, light and air do not contaminate the liquid
Equipped with most advanced Distributed Control System (DCS) automation technology, the facility has been set up with an investment of Rs. 200 crore
Lupin Vilfuro-G is the only FDC that uniquely combines Vilanterol, Fluticasone Furoate and Glycopyrronium Bromide
Amneal’s site in Matoda is one of the company’s 12 pharmaceutical manufacturing facilities
The audit was commenced for newly renovated manufacturing Block 1, Block 2, and Block 3
Subscribe To Our Newsletter & Stay Updated
_256_275.jpg)